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ABSTRACT Enteroaggregative Escherichia coli (EAEC) causes diarrhea and intestinal
inﬂammation worldwide. EAEC strains are characterized by the presence of aggrega-
tive adherence ﬁmbriae (AAF), which play a key role in pathogenesis by mediating
attachment to the intestinal mucosa and by triggering host inﬂammatory responses.
Here, we identify the epithelial transmembrane mucin MUC1 as an intestinal host
cell receptor for EAEC, demonstrating that AAF-mediated interactions between EAEC
and MUC1 facilitate enhanced bacterial adhesion. We further demonstrate that EAEC
infection also causes elevated expression of MUC1 in inﬂamed human intestinal tis-
sues. Moreover, we ﬁnd that MUC1 facilitates AAF-dependent migration of neutro-
phils across the epithelium in response to EAEC infection. Thus, we show for the ﬁrst
time a proinﬂammatory role for MUC1 in the host response to an intestinal patho-
gen.
IMPORTANCE EAEC is a clinically important intestinal pathogen that triggers intes-
tinal inﬂammation and diarrheal illness via mechanisms that are not yet fully under-
stood. Our ﬁndings provide new insight into how EAEC triggers host inﬂammation
and underscores the pivotal role of AAFs—the principal adhesins of EAEC—in driv-
ing EAEC-associated disease. Most importantly, our ﬁndings add a new dimension to
the signaling properties of the transmembrane mucin MUC1. Mostly studied for its
role in various forms of cancer, MUC1 is widely regarded as playing an anti-
inﬂammatory role in response to infection with bacterial pathogens in various tissues.
However, the role of MUC1 during intestinal infections has not been previously ex-
plored, and our results describe the ﬁrst report of MUC1 as a proinﬂammatory factor fol-
lowing intestinal infection.
KEYWORDS Escherichia coli, ﬁmbriae, inﬂammation, mucin
Enteroaggregative Escherichia coli (EAEC) causes endemic and sporadic diarrhealillness throughout the world (1–4). Several EAEC-associated disease outbreaks have
been reported (5–7), including a large food-borne outbreak caused by a Shiga toxin
(Stx)-producing EAEC strain in May 2011 in Germany leading to 3,842 conﬁrmed cases
and 54 deaths (8, 9). Asymptomatic colonization by EAEC has been linked to subclinical
inﬂammation and growth retardation (10).
Orally ingested EAEC bacteria adhere to the intestinal mucosa and form bioﬁlms,
thus allowing the bacteria to persistently colonize the intestinal tract (11). The speciﬁc
factors contributing to EAEC interaction with the intestinal mucosa are not fully
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understood. However, aggregative adherence ﬁmbriae (AAF), the principal adhesins of
EAEC, are thought to play a crucial role. Their involvement in bioﬁlm formation,
adherence to intestinal epithelial cells, and triggering of host inﬂammatory responses
has been well studied (12–15).
Five variants of the AAF major structural subunits have been described thus far:
AggA (AAF/I), AafA (AAF/II), Agg3A (AAF/III), Agg4A (AAF/IV), and Agg5A (16–19). The
AAFs are encoded on the large pAA virulence plasmid along with AggR, a transcription
factor regulating AAF biogenesis, and other putative EAEC virulence factors (11). The
AAFs belong to the Afa/Dr family of adhesins, which assemble via the usher/chaperone
pathway (20). The AAF structure comprises a major subunit (A) and a putative minor
subunit (B). The major subunits of different AAF variants share only ca. 25% amino acid
identity, but they are all positively charged, thus distinguishing them from other
members of the Afa/Dr family. This feature is thought to play a role in EAEC adhesion
(21).
EAEC does not invade the epithelial barrier, and so direct interactions between EAEC
and the intestinal epithelium are likely restricted to the apical surfaces of the cells. An
apically located cell receptor for EAEC has yet to be identiﬁed, although potential
binding partners have been found. The major pilin subunits of AAFs have been shown
to bind to extracellular matrix proteins, such as the glycoproteins ﬁbronectin and
laminin, as well as cytokeratin 8 (22, 23). However, given that none of these compounds
are present at the apical surface of healthy epithelium, other as yet unidentiﬁed
receptors likely mediate initial bacterial contact.
In the healthy human intestine, the epithelial cells are separated from the commen-
sal microbiota by a thick mucous barrier, which serves as a ﬁrst line of innate defense.
In the colon, the expanded outer mucus layer is rich in secreted mucins, which are large
glycoproteins that assemble into oligomeric structures. Mucins are heavily O-glycosylated,
decorated with sialic acid, galactose, fucose, N-acetylglucosamine (GlcNAc), and
N-acetylgalactosamine (GalNAc) glycans that vary in length and degree of branching.
These complex oligosaccharides serve as attachment sites and as a potential source of
nutrients for the microbiota (24). While the outer mucus layer entraps bacteria, the
inner mucus layer is thinner, and typically, bacteria do not penetrate this layer (25).
Transmembrane mucins are a key component of the inner mucus layer and consist of
a large extracellular O-glycosylated domain linked noncovalently to a cell membrane-
spanning domain, with a cytoplasmic tail that tethers the mucins to the epithelial
surface (26). Transmembrane mucins reach further out into the intestinal lumen than
any other membrane protein and are likely to be the ﬁrst point of direct contact
between host cells and pathogens capable of penetrating the secreted mucus layer,
such as EAEC (27).
Like secreted mucins, transmembrane mucins may act as releasable decoy mole-
cules on the apical surface to limit bacterial adherence, infection, and inﬂammation (28,
29). The oligosaccharides are attached to tandem repeats of amino acids within the
mucin backbone and may also serve as ligands for microbial adhesins (30, 31). Addi-
tionally, transmembrane mucins serve as sensors and regulators of the external milieu
and transmit signals through posttranslational modiﬁcations of their cytoplasmic tails
(32, 33). Deregulated transmembrane mucin production and signaling have been
associated with numerous types of cancers and inﬂammatory disorders (34).
MUC1 is a transmembrane mucin expressed by all human glandular epithelial
tissues and throughout the gastrointestinal tract at low levels (35). This mucin received
extensive attention in cancer research due to its aberrant expression at high levels in
human carcinomas and in inﬂamed tissue (26, 28, 36–38). Furthermore, MUC1 has also
been shown to act as a cell receptor for various pathogenic organisms, including
Pseudomonas aeruginosa, Campylobacter jejuni, and Helicobacter pylori (28, 39, 40).
In this study, we show that transmembrane mucins are receptors for the AAF
adhesins of EAEC on the intestinal epithelium. Moreover, we demonstrate that the AAFs
elicit intestinal inﬂammation through MUC1-mediated host cell signaling.
Boll et al. ®
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RESULTS
MUC1 is a cell receptor for EAEC. Previous studies have shown that EAEC strains
evoke host inﬂammation through AAF-mediated binding to the intestinal epithelial
surface (12, 13). We have shown that EAEC strain 042 induces transepithelial migration
of polymorphonuclear neutrophils (PMNs) across polarized T84 cell monolayers by
activating apical release of an eicosanoid-based PMN chemoattractant, which guides
PMNs across the intestinal epithelium (41). EAEC strains lacking AAF were unable to
trigger host cell inﬂammatory signaling, suggesting that this process is likely mediated
by binding of AAF to an unknown apical surface receptor (13).
We have previously reported that AAF adhesins induce hemagglutination; the
species-speciﬁc hemagglutination pattern differs among the ﬁmbrial variants (17). We
have shown that AAF/II causes temperature-dependent hemagglutination of human
type A erythrocytes (42). Since some diarrheagenic E. coli adhesins recognize sialylated
receptors, we tested whether hemagglutination in AAF/II-producing strain 042 would
be reduced by treatment of the erythrocytes with neuraminidase. Treatment of eryth-
rocytes with neuraminidase for 20 min completely abolished the hemagglutination
phenotype (not shown).
As our data suggested that AAF/II binds to a sialylated receptor on erythrocytes, we
hypothesized that the AAF/II receptor on epithelial cells would be a sialylated glyco-
protein; the most abundant membrane-associated glycoproteins on human epithelial
cell surfaces are the transmembrane mucins. To further investigate the potential
involvement of mucins in mediating EAEC binding and/or inﬂammation, we focused
our attention on the transmembrane mucin MUC1, which acts as an adhesion target for
pathogens, including Pseudomonas aeruginosa, Campylobacter jejuni, and Helicobacter
pylori (28, 29, 39). To determine whether MUC1 could also serve as a receptor for EAEC,
we evaluated bacterial adhesion to healthy HEK293 cells that do not express MUC1
compared to HEK293 cells stably expressing human MUC1 (see Fig. S1 in the supple-
mental material). Both the wild-type EAEC 042 (wt 042) strain and the 042ΔaafA strain
expressed a green ﬂuorescent protein (GFP) reporter, and bacterial adhesion was
quantiﬁed by ﬂuorescence microscopy. We found that the 042 wt strain bound at
signiﬁcantly higher levels to MUC1-positive HEK293 cells than to MUC1-negative cells,
whereas the 042ΔaafA strain failed to bind to either cell line (Fig. 1A and C). Moreover,
as shown in Fig. 1B, we observed colocalization of 042 wt strain with MUC1 on the
surfaces of MUC1-positive HEK293 cells.
MUC1 oligosaccharides carry terminal sialic acids (35). To determine the importance
of sialic acid residues on MUC1 for binding of EAEC, we pretreated MUC1-positive
HEK293 cells with neuraminidase for 1 h prior to infection with the 042 wt strain. As
shown in Fig. 1D, this treatment signiﬁcantly reduced bacterial binding, suggesting that
sialic acid is required for recognition of MUC1 by AAF.
EAEC strain 042 expresses AAF variant II, one of ﬁve subtypes that share a low level
of similarity. We therefore examined whether the interaction with MUC1 was speciﬁc to
this ﬁmbrial subtype. HEK293-MUC1 cells were infected with EAEC strains expressing
other AAF variants, including strains 17-2 (AAF/I), 55989 (AAF/III), and C1010-00 (AAF/
IV). The presence of MUC1 signiﬁcantly enhanced binding of strains 17-2 and 55989 to
HEK293 cells (Fig. 1E). Surprisingly, the opposite effect was observed with strain
C1010-00.
Collectively, these ﬁndings demonstrate that MUC1 is a host cell receptor for EAEC
strains and that binding is mediated by speciﬁc AAFs. This binding is at least partially
dependent on MUC1 sialic acid residues.
EAEC binds to MUC1 on the surfaces of intestinal epithelial cells. We next
investigated whether these ﬁndings in a transfected cell line extended to bacterial
binding of native MUC1 expressed on the epithelial surface. Human colon cancer-
derived T84 cells produce mucins (including MUC1), polarize to form tight epithelial
barriers, and serve as a useful model of intestinal epithelia. EAEC bacteria adhere to the
apical surfaces of polarized T84 cells and can induce neutrophil transmigration in the
Fimbriae-Mediated Inﬂammation by EAEC through MUC1 ®
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physiologically relevant basolateral-to-apical direction (41). We were able to knock
down MUC1 expression in T84 cells using lentiviral short hairpin RNA (shRNA) con-
structs targeting MUC1. Of the ﬁve constructed MUC1 shRNA cell lines, we chose one
with a signiﬁcant decrease in MUC1 expression at both the mRNA and protein levels
(Fig. S2) for further experimentation.
T84 MUC1 shRNA cells were infected with the different EAEC strains described above
as well as the AAF/I-expressing Stx-EAEC German outbreak strain cured of its Stx-
encoding phage (C227-11 cu) (43). For a control, we also included diffusely adhering
E. coli strain IH11128. IH11128 expresses Dr ﬁmbriae, which are related to AAF ﬁmbriae
but bind speciﬁcally to decay-accelerating factor (DAF)/CD55 on the surfaces of T84
cells, and therefore should not be affected by the lack of MUC1 (44). The 042 strain
adhered signiﬁcantly less to T84 MUC1 shRNA cells than to control T84 cells (Fig. 2). In
contrast, MUC1 knockdown did not signiﬁcantly affect binding of strain C227-11 cu,
55989, or C1010-00 or the diffusely adherent E. coli IH11128 strain.
EAEC-induced PMN migration is mediated by MUC1. Transmembrane mucins are
increasingly recognized for their involvement in host cell signaling cascades via their
cytoplasmic tails (34). MUC1 has been shown to play an anti-inﬂammatory role in
response to lung and gastric infections (33, 40, 45). However, its role in response to
intestinal infection has not been determined. Given that AAFs are critical for induction
of inﬂammation by EAEC, we sought to determine whether the interaction between
AAFs and MUC1 triggers EAEC-induced inﬂammation. T84 MUC1 shRNA cells were
infected with various EAEC strains, and the ability to induce neutrophil transepithelial
migration was measured.
Reduction of MUC1 expression profoundly reduced the ability of EAEC strains 042
and C227-11 cu to induce PMN migration compared with infection of control cells
FIG 1 MUC1 is a cell receptor for EAEC. (A) HEK293 cells transfected with pcDNA3 or pcDNA3-MUC1 were infected
in suspension with EAEC strain 042 or with its isogenic ﬁmbrial mutant (042aafA), each expressing a GFP reporter
and analyzed by ﬂuorescence microscopy (FM). Cell membranes were stained with FM4-64FX, and DNA was stained
with DAPI. (B) Uninfected and EAEC 042-infected HEK293pMUC1 cells were stained with FITC-conjugated anti-
MUC1 MAb and DAPI and analyzed by FM. Bacteria were stained with M4-FX64. (C) HEK293-pcDNA-MUC1 cells
were infected in suspension as described above in panel A, and bacteria that adhered to cells were enumerated
microscopically. (D) HEK293-pcDNA3-MUC1 cells were treated with two concentrations (20 U and 40 U) of
neuraminidase (Neu) for 1 h before infection with strain 042 followed by quantiﬁcation of bacterial adherence as
described above for panel C. (E) HEK293 cells not expressing or expressing recombinant MUC1 were infected with
EAEC strain 17-2 (which expresses AAF/I), 55989 (AAF/III), or C1010-00 (AAF/VI), followed by quantiﬁcation of
bacterial adherence as described above for panel C. Bars represent the means of at least three independent
experiments, with the error bars indicating standard deviations (SD) (error bars). Values that are signiﬁcantly
different (P  0.05) are indicated by a bar and asterisk.
Boll et al. ®
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(Fig. 3A). When we infected MUC1 knockdown cells with EAEC type strains 55989 and
C1010-00, we observed reduced inﬂammatory migration similar to the phenotypes of
042 and C227-11 cu (Fig. 3B). Collectively, these results indicate that MUC1 is involved
in EAEC-induced inﬂammation regardless of the AAF variant expressed.
In addition to MUC1, several other transmembrane mucins such as MUC3, MUC4,
and MUC13 are expressed in the gastrointestinal tract (34). MUC13 is highly expressed
in healthy colonic epithelium, where EAEC has been shown to bind abundantly (46, 47).
Moreover, MUC13 has been implicated in intestinal inﬂammation (33). We therefore
sought to determine whether MUC13 also acts as an inﬂammatory receptor for EAEC.
A T84 MUC13 shRNA cell line with greatly reduced MUC13 expression was generated
(Fig. S2). MUC1 expression was not altered in the T84 MUC13 shRNA cell line and vice
versa (data not shown). As shown in Fig. 3C, MUC13 knockdown did not affect the
ability of strain 042 or C227-11 cu to trigger neutrophil transepithelial migration,
suggesting that the AAFs speciﬁcally trigger inﬂammation through MUC1.
Puriﬁed AAFs elicit MUC1-dependent inﬂammation in the presence of com-
mensal E. coli. Having shown that AAFs bind to MUC1 and that MUC1 contributes to
neutrophil inﬁltration, we next sought to establish a direct link between AAFs and
MUC1-induced inﬂammation. To this end, puriﬁed AAFs from EAEC strains C227-11 cu
and 042 (expressing AAF/I and AAF/II, respectively) were assessed for their ability to
trigger inﬂammation. Both puriﬁed AAF/I and AAF/II alone failed to elicit neutrophil
transmigration in our model system (Fig. S3). However, when applied to T84 cells in
combination with E. coli K-12 strain MG1655, which alone does not induce transmigra-
tion, both types of AAF promoted PMN migration in a dose-dependent manner
FIG 2 EAEC binds to MUC1 on the surfaces of intestinal epithelial cells. Monolayers of scrambled control
(Scr. cont.) T84 cells or cells with MUC1 shRNA were infected with EAEC strain 042, C227-11 cu (AAF/I),
55989, or C1010-00 or diffusely adherent E. coli (DAEC) strain IH11128. Cell-adhered bacteria were then
enumerated by plating. Bars represent the means of at least three independent experiments plus SD. ***,
P  0.001.
FIG 3 MUC1 is involved in EAEC-induced PMN migration. (A to C) Monolayers of scrambled control T84 cells or cells with MUC1 shRNA
(A and B) or MUC13 shRNA (C) were infected apically with EAEC strains. HBSS buffer (-) and the PMN chemoattractant N-formyl-
methionyl-leucyl-phenylalanine (fMLP) were included as negative and positive controls, respectively. The data are expressed as the
means plus SD for at least triplicate samples, and the data shown are from one representative experiment of at least three
independent experiments performed with similar results. ***, P  0.001; **, P  0.01; *, P  0.05.
Fimbriae-Mediated Inﬂammation by EAEC through MUC1 ®
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(Fig. 4A). The same response was observed when AAFs were combined with laboratory
E. coli K-12 hybrid strain HB101 or the commensal E. coli strain F-18 (data not shown).
This suggests that AAFs are sufﬁcient to confer an inﬂammatory phenotype onto
bacteria that are normally incapable of triggering inﬂammation in this model system.
Neither AAF variant was found to affect adhesion of the E. coli MG1655 strain to T84
cells (data not shown), suggesting that the inﬂammatory phenotype does not result
from increased binding of the bacteria.
In keeping with results using EAEC strains, the inﬂammation induced by trans-
expression of AAFs depended on MUC1 at the cell surface. As shown in Fig. 4D, MUC1
knockdown signiﬁcantly reduced the ability of MG1655 to induce PMN migration in the
presence of AAFs. Taken together, these ﬁndings strongly support our hypothesis that
EAEC triggers inﬂammation through interactions between AAFs and MUC1.
Although puriﬁed AAFs alone were unable to induce PMN migration, it remains
possible that AAFs alone are capable of eliciting inﬂammation but that they need to
function in the spatial and structural context of a bacterial cell. In an attempt to mimic
the structure of AAFs bound to the bacterial surface, we coated beads (Polybead
polystyrene microspheres) with puriﬁed AAF/II and veriﬁed coating by immunoblot
analysis (Fig. S4). However, as shown in Fig. 4B, AAF-coated beads failed to induce PMN
migration. We next assessed whether AAFs require the presence of live E. coli to trigger
PMN migration. As shown in Fig. 4C, heat-killing E. coli MG1655 prior to mixing with
AAFs and infecting T84 cells abolished the inﬂammatory phenotype. This indicates that
live bacteria provide a second costimulatory signal required for triggering inﬂamma-
tion.
EAEC infection enhances MUC1 expression in human intestinal xenografts in
an AAF-dependent manner. In contrast to colon carcinomas, MUC1 is not present at
FIG 4 Puriﬁed AAFs elicit MUC1-dependent PMN transepithelial migration in the presence of commensal E. coli.
(A and C) T84 cell monolayers were infected with live or heat shock-killed commensal E. coli strain MG1655 in the
presence or absence (-) of AAF/I or AAF/II, respectively, and assessed for PMN transmigration. (B) T84 monolayers
were exposed to beads coated with puriﬁed AAF/II or coated with BSA as a negative control and assessed for PMN
migration. (D) Monolayers or scrambled control or MUC1 shRNA T84 cells were infected with live E. coli MG1655
in the presence of 10 g AAF/II and assessed for PMN transmigration. The data are expressed as the means plus
SD for at least triplicate samples and represent one of at least three independent experiments performed with
similar results. ***, P  0.001; **, P  0.01; *, P  0.05.
Boll et al. ®
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signiﬁcantly high levels in healthy human colon (48). However, infection of mice with
either Campylobacter jejuni or Citrobacter rodentium leads to increased MUC1 expres-
sion in inﬂamed intestines (26, 28). To investigate whether EAEC inﬂuences MUC1
expression in native intestinal tissues, we examined previously infected human intes-
tinal xenografts (13) for MUC1 expression. These grafts develop into morphologically
normal human intestine and secrete mucins (49). As shown in Fig. 5, staining with a
human MUC1-speciﬁc antibody revealed only minimal MUC1 expression in the grafts
treated with buffer or infected with the HB101 strain. In contrast, in grafts infected with
the wild-type 042 strain, MUC1 expression was highly elevated at the epithelial surface.
Infection with an HB101 strain expressing AAF/II-encoding genes also increased MUC1
expression, thus strongly suggesting that AAFs are sufﬁcient to trigger elevated MUC1
expression on the intestinal epithelium.
DISCUSSION
EAEC has gained increasing attention in recent years with a rise in outbreaks and
recognition of its importance in multiple clinical settings. However, while much is
known about EAEC pathogenesis, a key missing step has been the lack of identiﬁcation
of a host cell receptor on the surface of the intestinal epithelium. Here, we have
identiﬁed the transmembrane mucin MUC1 as one such receptor.
We demonstrate that binding of EAEC to MUC1 is mediated by the AAFs, which
serve multifunctional roles in the pathogenesis of this organism. Previous studies have
demonstrated binding of AAFs to other cell surface components, including the extra-
cellular matrix proteins ﬁbronectin and laminin (21, 23). The major pilin subunits of
AAF/I and AAF/II are both highly positively charged at physiologic pH, and the
attachment of these two AAF variants to ﬁbronectin is primarily based on electrostatic
interactions (21). This raises the question of whether the AAF-MUC1 interactions are of
a similar nature. The MUC1 glycans feature terminal sialic acids, which contribute
negative charge. We found that pretreatment of MUC1-expressing HEK293 cells with
neuraminidase (to release sialic acid) reduced binding of EAEC strain 042 to the cells.
However, residual binding was still observed, which could indicate that sialic acid is one
component of a larger oligosaccharide structure involved in EAEC binding.
Interestingly, we found that MUC1 is not the only transmembrane mucin to which
EAEC binds. Adherence of EAEC strains expressing AAF variant I, II or III to T84 cells was
attenuated when MUC13 expression was reduced (unpublished observations). In con-
trast, MUC1 reduction signiﬁcantly attenuated binding of only the 042 strain (which
FIG 5 EAEC infection enhances MUC1 expression in human intestinal xenografts in an AAF-dependent manner.
Human fetal small intestinal xenografts were previously infected for 24 h with wild-type 042, an 042 isogenic AAF/II
mutant, E. coli strain HB101, HB101 carrying an AAF/II-encoding plasmid, or sterile HBSS (13). Here, tissue sections
(shown in blue) were stained with DAPI, and MUC1 (shown in red) was stained using human MUC1 (VU4H5) MAb.
Photographs show representative tissues for each treatment.
Fimbriae-Mediated Inﬂammation by EAEC through MUC1 ®
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expresses AAF/II). Binding of the C1010-00 strain, expressing AAF/IV, was not affected
by reduction of either MUC1 or MUC13. It is possible that the more neutral surface
charge of the AAF/IV major pilin subunit makes this particular adhesin less adept at
binding mucins (17), or that redundancy prevented a single mucin knockdown from
affecting C1010-00 binding. Further studies will elucidate the exact nature of the
AAF-mucin interactions and the role of the oligosaccharide side chains.
In addition to potentially serving as decoys for microbes that penetrate the outer
mucus layer, transmembrane mucins are involved in complex biological processes,
including inﬂammatory signaling pathways (34). Previous work from our group has
demonstrated that EAEC induces AAF-dependent migration of PMNs across intestinal
epithelium (13). We have now identiﬁed MUC1 as a signaling surface receptor for AAFs
and have demonstrated that EAEC exploits MUC1 to trigger PMN migration. In fact,
reduced MUC1 expression attenuated the inﬂammatory response to EAEC strains
regardless of the AAF variant expressed. While other transmembrane mucins also have
signaling roles, reduced MUC13 expression did not impact EAEC-induced PMN migra-
tion in our model. This ﬁnding suggests that MUC1 plays a unique and critical role in
mediating host inﬂammatory responses to EAEC and may act as a sensor of bacterial
infection that triggers host cells to mount an inﬂammatory response.
Interestingly, we observed that puriﬁed AAFs combined with noninﬂammatory
commensal E. coli strains could also drive PMN migration in a MUC1-dependent
manner. Puriﬁed AAFs were unable to elicit inﬂammation by themselves, instead
requiring the presence of live bacteria. This implies that bacteria provide a costimula-
tory signal required for the AAFs to activate cellular signaling. The fact that boiling the
commensal E. coli prior to infection in the presence of AAFs abolished the inﬂammatory
phenotype suggests that the costimulatory signal is heat-labile, ruling out molecules
such as lipopolysaccharide (LPS) and peptidoglycan unless delivered via a mechanism
that requires live bacteria. We also considered the possibility that other bacterial
secreted compounds might provide a secondary signal required for AAFs to trigger the
inﬂammatory response. However, we did not detect PMN migration following exposure
of T84 cells to E. coli MG1655 supernatants in the presence or absence of AAF/II (data
not shown). Moreover, we have previously shown that the 042ΔﬂiC strain, which lacks
ﬂagella, is equally capable as the 042 wt strain of inducing PMN migration, thereby
ruling out ﬂagellin out as a candidate (13). Last, we examined whether type 1 ﬁmbriae,
which bind to D-mannose residues on eukaryotic surfaces, could be involved. These
adhesins are highly common in both commensal E. coli, including MG1655, and
pathogenic E. coli and have been implicated in inﬂammation (50). Nevertheless, pre-
treatment with 1% mannose did not reduce the ability of the 042 wt or MG1655 strain
in the presence of AAF/II to drive PMN migration (data not shown). However, type 1
ﬁmbriae could still prove to be the costimulatory inﬂammatory signal, e.g., by
mannose-independent host cell receptor recognition of the ﬁmbriae. Further studies
are ongoing in an attempt to identify the exact nature of this costimulatory signal.
MUC1 has been implicated in numerous cell signaling pathways, including those
related to inﬂammation (32). MUC1 signaling can be mediated through phosphoryla-
tion of its cytoplasmic tail by growth factor receptors in response to external stimuli
such as hypoglycosylation or bacterial contact, which in turn may lead to phosphory-
lation of kinases anchored to the tail of the glycoprotein. For instance, P. aeruginosa
ﬂagellin has been shown to bind to airway epithelial MUC1, leading to extracellular
signal-regulated kinase (ERK) activation (51). External stimuli may also cause the tail to
be cleaved and localized to the cell nucleus in complex with other proteins leading to
transcriptional activation of proliferative and inﬂammatory genes, including the MUC1
gene itself (32, 52).
Most studies linking MUC1 to inﬂammation suggest an anti-inﬂammatory function.
For instance, MUC1 inhibits nuclear factor NF-B activity and interleukin-8 (IL-8) secre-
tion in gastric epithelium in response to H. pylori infection (53). MUC1 also downregu-
lates neutrophil inﬂux in airway epithelium following P. aeruginosa infection (45). In
another study, MUC1 suppressed conjunctivitis in mice caused by Staphylococcus and
Boll et al. ®
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Streptococcus species (54). Our results identifying a proinﬂammatory role for MUC1 in
response to an intestinal pathogen are novel and suggest that the role of MUC1 in
inﬂammation is complex and likely depends on a variety of factors, including the
speciﬁc pathogen and the site of infection. EAEC infection of epithelial cells triggers
AAF-dependent basolateral release of IL-8, the prototypical neutrophil-attracting chemo-
kine, facilitating recruitment of neutrophils out of the vasculature (12). We therefore
sought to determine whether MUC1 also plays a role in mediating this event. However,
no signiﬁcant difference in IL-8 secretion was observed following EAEC 042 infection of
MUC1-reduced T84 cells compared to control cells (unpublished observations). Thus, it
appears that a distinct EAEC-activated host cell pathway is required for recruitment of
neutrophils to the basal membrane.
We have not yet determined how AAF binding to MUC1 drives intestinal inﬂamma-
tion, but our understanding of how EAEC infection induces neutrophil inﬂux suggests
possible hypotheses. EAEC triggers epithelial synthesis of the PMN chemoattractant
hepoxilin A3 (HXA3) in a conserved manner also utilized by Salmonella enterica serovar
Typhimurium (41). In the case of S. Typhimurium, HXA3 is secreted through the apically
located efﬂux transporter MRP2, and localization of MRP2 to the apical surface is
mediated by the ERM (ezrin, radixin, and moesin) protein ezrin (55). Notably, ezrin has
been shown to colocalize with MUC1 in breast carcinomas (56). The MUC1 cytoplasmic
tail has also been shown to associate with protein kinase C- (PKC-), which we have
previously implicated in EAEC-induced PMN migration (41, 57). Further studies will
determine whether AAF binding to MUC1 is associated with changes in ezrin and PKC-
localization or phosphorylation in a way that drives HXA3/MRP2 inﬂammation during
EAEC infection.
While MUC1 is found on all epithelial surfaces, it is sparse in the healthy human
intestine (48). However, MUC1 has been found to be upregulated in the inﬂamed
intestines of mice infected with enteric pathogens as well as in human patients with
ulcerative colitis (26, 28, 58). We found that infection with EAEC 042 strongly upregu-
lated epithelial MUC1 expression and that stimulation of MUC1 expression depended
on bacterial expression of AAFs. Thus, it is possible that EAEC is also capable of inducing
enhanced MUC1 expression in infected individuals and that the pathogen can exploit
this to its own advantage by inducing a proinﬂammatory neutrophil response that
promotes bacterial pathogenesis. In conclusion, we have identiﬁed MUC1 as a cellular
receptor for EAEC and demonstrated for the ﬁrst time that MUC1 mediates a proin-
ﬂammatory effect in response to an intestinal pathogen.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The bacterial strains used in this study are listed in Table 1.
Bacteria were cultured in Luria-Bertani (LB) broth or agar. For immunoﬂuorescent staining, EAEC
prototype strains 042, 042ΔaafA, C1010-00, 17-2, and 55989 were transformed with pEGFP (EGFP stands
for enhanced GFP) plasmid (Clontech), and carbenicillin-resistant clones were selected on LB medium.
Cell culturing. HEK293 cells stably expressing human MUC1 in the pcDNA3 vector (293MUC1) or
empty vector pcDNA3-HEK293 (293 cells) have been previously described (39). Cells were routinely
cultured in Dulbecco modiﬁed Eagle medium (DMEM), 10% heat-inactivated qualiﬁed fetal bovine serum
(FBS), antibiotics, and 200 g/ml of G418 (Sigma).
TABLE 1 Bacterial strains used in this study
Strain Description Reference
042 Wild-type EAEC strain expressing AAF/II 59
17-2 Wild-type EAEC strain expressing AAF/I 60
JM221 Wild-type EAEC strain expressing AAF/I 19
55989 Wild-type EAEC strain expressing AAF/III 18
C1010-00 Wild-type EAEC strain expressing AAF/IV 17
042 aafA Strain 042 with TnphoA inserted into the aafA gene; previously designated mutant 3.4.14 42
C227-11 cu EAEC strain C227-11 expressing AAF/I cured of the Stx2a-bearing phage 43
IH11128 Diffusely adherent E. coli strain 61
MG1655 Commensal E. coli strain 62
F-18 Commensal E. coli strain 63
HB101 Nonﬁmbriated E. coli strain 64
Fimbriae-Mediated Inﬂammation by EAEC through MUC1 ®
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T84 cells were cultured in DMEM with nutrient mixture F-12 (DMEM–F-12) (Invitrogen) containing
10% FBS, 100 U/ml penicillin, and 100 g/ml streptomycin. Inverted polarized T84 cell monolayers were
constructed as previously described (13).
Lentiviral transduction of T84 cells with shRNA constructs against MUC1 or MUC13. Sequence-
veriﬁed short hairpin RNA (shRNA) lentiviral plasmids in pLKO.1-puromycin vector for MUC1 or MUC13
silencing in human cells were obtained from Open Biosystems through the RNAi (RNA interference) Core
Facility at University of Massachusetts Medical School. For production of lentiviral particles, three
components were transfected into HEK 293T cells: (i) pLKO.1 vector containing shRNA; (ii) a packaging
vector psPAX2 containing gag, pol, and rev genes; and (iii) envelope vector pMD.2G. For transfection, a
mixture of 12 g plasmid with a gene coding for shRNA plus 9 g packaging plasmid plus 3 g envelope
plasmid combined with TransIT-293 transfection reagent (Mirus) in 1 ml Opti-MEM serum-free medium
was added to HEK 293T cells plated to 80% conﬂuence in 10-cm petri dishes. Production of lentiviruses
was enhanced by replacement of the cell culture medium 24 h posttranfection. Twenty-four hours later,
the viral supernatants were harvested, passed through Whatman Puradisc 0.45-m ﬁlters, and added
with 8 g/ml Polybrene to T84 cells plated to 20% conﬂuence in a six-well plate. After 24 h, the
transduction procedure was repeated. The next day, the T84 cells were passaged into T-25 25-cm2 ﬂasks
containing regular T84 cell medium. Twenty-four hours later, selection for stable shRNA-containing cell
was initiated by replacing medium with fresh medium containing 5 g/ml puromycin.
Binding assays. Adhesion of EAEC strains to HEK293 cells was performed by two procedures. In the
ﬁrst procedure, HEK293 and HEK293MUC1 cells were grown on eight-well Millicell EZ glass slides
(Millipore) coated with poly-L-lysine (Sigma) and incubated at 37°C for 1 h with EAEC 042 previously
stained with the lipophilic probe FM4-64FX (Life Technologies, Inc.), which ﬂuoresces upon binding to
plasma membranes (red ﬂuorescence). Subsequently, cells were washed two times with Dulbecco’s
phosphate-buffered saline (PBS) (pH 7.4) and ﬁxed with formalin for analysis by ﬂuorescence microscopy.
In the second procedure, cells were grown on monolayers, detached and rounded with PBS containing
0.35 mM EDTA, and washed with PBS. A total of 2  106 cells in suspension were stained with FM4-64FX
for membranes and 4=,6=-diamidino-2-phenylindole (DAPI) for nucleus visualization for 5 min, followed
by incubation with EAEC expressing GFP at a multiplicity of infection (MOI) of 20 in DMEM without FBS
and antibiotics for 1 h at 37°C. The cells were then washed three times with HBSS and resuspended in
5% formalin for analysis.
Adhesion of E. coli strains to T84 cells was performed by plating and CFU determination as previously
described (13).
Immunoﬂuorescence. Fixed HEK293 cells were blocked with PBS containing 2% FBS, incubated with
ﬂuorescein isothiocyanate (FITC)-conjugated mouse anti-MUC1 monoclonal antibody (MAb) (BD) (diluted
1:200) for 1 h, and washed three times with PBS containing Tween 20. After the cells were washed, the
coverslips were mounted using ProLog antifade DAPI (Life Technologies) and PolyMount seller (Poly-
sciences, Inc.). The immunostaining was analyzed and photographed using epiﬂuorescence microscopy
(Olympus BX51).
Coating of polystyrene beads with puriﬁed AAF ﬁmbriae. AAF ﬁmbriae from EAEC strains were
puriﬁed by the method of Izquierdo et al. (23). Forty microliters of Polybead polystyrene microspheres
(Polysciences Inc.) was suspended in 360 l of 0.1 M borate buffer (pH 8.5) (Polysciences Inc.), spun down,
and resuspended in borate buffer three times. Puriﬁed AAF/II or bovine serum albumin (BSA) (negative
control) was then added to the beads in borate buffer (total volume of 400 l) and incubated overnight.
The coated beads were then spun down, washed three times in Hank’s balanced salt solution (HBSS), and
ﬁnally resuspended in HBSS to a ﬁnal volume of 400 l.
For conﬁrming proper coating, the ﬁnal resuspensions were separated on a polyacrylamide gel and
immunoblotted using AafA Rab (23).
Histological procedures on human intestinal xenografts. Cryosections of previously infected
human intestinal xenografts mounted on glass slides (13) were ﬁxed in 4% paraformaldehyde (in PBS),
washed, and blocked in 1% FBS and 0.1% Triton X-100 (in PBS), incubated overnight in blocking buffer
with MUC1 (VU4H5) MAb (Abcam, Inc.) (1:100), then washed, and incubated with Alexa Fluor 633. After
the slides were washed, the slides were mounted using DAPI-containing Vectashield solution (Vector)
and analyzed using a ﬂuorescence microscope.
SUPPLEMENTAL MATERIAL
Supplemental material for this article may be found at https://doi.org/10.1128/mBio
.00717-17.
FIG S1, PDF ﬁle, 0.7 MB.
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